REVEAL GENOMICS, S.L.: REVEAL GENOMICS? ANNOUNCES RESEARCH COLLABORATION IN HER2+ BREAST CANCER

The agreement with Dana-Farber Cancer Institute consists of using HER2DX? to analyze tumor samples from more than 500 patients with early-stage HER2+ breast cancer across three clinical trials

Related Keywords

San Antonio ,Texas ,United States ,Hebron ,Israel General ,Israel ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Saram Tolaney ,Kostenloser Wertpapierhandel ,Adriana Herrera ,Patricia Villagrasa Gonzalez ,Aleix Prat ,Sara Tolaney ,University Of Barcelona ,Division Of Breast Oncology ,Twitter ,Hebron Institute Of Oncology ,Women Cancers At Dana Farber Cancer Institute ,Dana Farber Cancer Institute ,Susanf Smith Center ,New England Journal ,Clinical Oncology ,San Antonio Breast Cancer Meeting ,Breast Oncology ,Associate Director ,Dana Farber Cancer ,Hebron Institute ,Reveal ,Genomics ,Nnounces ,Research ,Collaboration ,Ther2 ,Breast ,Dancer ,